February 9, 2021
The Guardian on February 7, published an insightful statement from Rwandan President, Paul Kagame, on the importance of vaccinating Africans, entitled: Until Africans get the Covid vaccinations they need, the whole world will suffer.
President Kagame correctly concludes: Ensuring equitable access to vaccines globally during a pandemic is not only a moral issue, but an economic imperative to protect the wellbeing of people everywhere. But when will Africa get the protection it needs? If all lives are equal, why isn’t access to vaccines?
I completely agree with President Kagame. It is both immoral and economically stupid not to vaccinate every human being as quickly as possible, and without cost. Let me briefly summarize.
1) Every human being is bestowed by the Creator with the power of creative reason. Thus, every human being is sacred. Society should spare no effort to preserve human life. This is a requirement of civilization. After all, we are not Malthusians, who believe the world is over populated.
2) Until the Covid19 virus is eliminated across the world, no nations or peoples are safe from the virus and its mutations. Therefore, it is criminally stupid not to vaccinate every single person on the planet as quickly as possible.
3) The global economy will also suffer, if more human beings are unable to work or die due to sickness from Covid19. Economic production and trade will shrink, lowering the physical standard of living throughout the world.
4) It is cheaper to vaccinate everyone for free than pay for exorbitant medical costs to treat patients with Covid19.
5) Let us use this horrible crisis to unite all nations in a global effort to not only eradicate this deadly virus, but upgrade the healthcare system of African nations, enabling them to properly respond to the needs of their people
Below is the full text of President Kagame’s column.
The current situation with regard to the access and distribution of Covid-19 vaccines vividly illustrates the decades-old contradictions of the world order.
Rich and powerful nations have rushed to lock up supply of multiple vaccine candidates. Worse, some are hoarding vaccines – purchasing many times more doses than they need. This leaves African and other developing countries either far behind in the vaccine queue, or not in it at all.
There are worrying signs of vaccine nationalism in Europe and North America. The pressures on political leaders to vaccinate all their citizens before sharing supplies with others is understandable. But forcing smaller or poorer countries to wait until everyone in the north has been catered for is shortsighted.
Delaying access to vaccines for citizens of developing countries is ultimately many times more costly. The pandemic will rage on, crippling the global economy. New mutations may continue to emerge at a more rapid pace. The world risks reversing decades of human development gains and eclipsing the 2030 sustainable development goals.
In this context, the billions of dollars it would cost to distribute vaccines across the developing world is not particularly high, given the return on the investment. Doing so would unlock global commerce, which would benefit all trading nations during the long road to economic recovery that lies ahead of us. We need global value chains to be fully operational again and to include everyone.
Last year, the world came together to provide additional fiscal space for developing countries through the debt service suspension initiative at the G20. This helped governments in Africa pay for their Covid responses and provide additional social protection, thereby preventing the worst outcomes. We shouldn’t lose that spirit now and give in to an unfortunate erosion of global solidarity.
The Covax facility, led by the World Health Organization, was supposed to ensure doses for 20% of Africa’s people – right from the start and at the same time as richer countries. However, nearly two months after the first vaccines have been administered, it is still not clear when African nations will be able to start immunising people, though the first doses may begin reaching the continent later this month.
What can be done in practical terms? The rich world can help developing countries get the same fair prices that they have already negotiated for themselves. One pharmaceutical firm is reportedly planning to charge $37 per dose for “small orders”. Recently, one African country reported being asked to pay more than double the price that the European Union had negotiated for the same product.
During natural disasters, price gouging for essential supplies is illegal. It should not be tolerated for vaccines during a pandemic either. If prices are fair, and Africa is allowed to place orders, many countries on the continent would be willing and able to pay for themselves. But, given the current market structure, they will need active support from more powerful countries to do so.
The African Union and Afreximbank have set up the Africa Medical Supplies Platform to help countries secure financing by providing advance commitment guarantees of up to $2bn to manufacturers. The platform has negotiated an initial order of 270m doses, but this is still very far from the 60% coverage Africa needs to achieve some measure of herd immunity, and there is no telling when those supplies will be available.
Africa is not sitting back and waiting for charity. We have learned our lessons from the past. All we ask for is transparency and fairness in vaccine access, not the protectionism currently in play.
Watch my interview on RT TV from January: Africa must be vaccinated
Lawrence Freeman is a Political-Economic Analyst for Africa, who has been involved in economic development policies for Africa for over 30 years. He is the creator of the blog: lawrencefreemanafricaandtheworld.com